Dopamine D2 receptor occupancy predicts catalepsy and the suppression of conditioned avoidance response behavior in rats
暂无分享,去创建一个
Shitij Kapur | Franco Vaccarino | S. Kapur | A. Soliman | F. Vaccarino | Marie-Louise G. Wadenberg | Alexandra Soliman | Corey Jones | M. Wadenberg | Corey Jones | Alexandra Soliman
[1] M L Wadenberg,et al. A novel computer-controlled conditioned avoidance apparatus for rats. , 1997, Journal of pharmacological and toxicological methods.
[2] A. C. V. van Grootheest,et al. [Atypical antipsychotics]. , 2000, Nederlandsch tijdschrift voor geneeskunde.
[3] G. Uppfeldt,et al. Efficacy, safety and tolerability of raclopride, a specific D2 receptor blocker, in acute schizophrenia: an open trial. , 1989, International clinical psychopharmacology.
[4] S. Ahlénius,et al. Suppression of conditioned avoidance behavior by the local application of (−)sulpiride into the ventral, but not the dorsal, striatum of the rat , 1990, Biological Psychiatry.
[5] P. Seeman,et al. Rapid release of antipsychotic drugs from dopamine D2 receptors: an explanation for low receptor occupancy and early clinical relapse upon withdrawal of clozapine or quetiapine. , 1999, The American journal of psychiatry.
[6] V. Hillegaart,et al. Involvement of extrapyramidal motor mechanisms in the suppression of locomotor activity by antipsychotic drugs: A comparison between the effects produced by pre- and post-synaptic inhibition of dopaminergic neurotransmission , 1986, Pharmacology Biochemistry and Behavior.
[7] G Blomqvist,et al. Comparison of the Transient Equilibrium and Continuous Infusion Method for Quantitative PET Analysis of [11C]Raclopride Binding , 1998, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[8] Douglas L. Jones,et al. From motivation to action: Functional interface between the limbic system and the motor system , 1980, Progress in Neurobiology.
[9] Christer Halldin,et al. Central D2-dopamine receptor occupancy in relation to antipsychotic drug effects: A double-blind PET study of schizophrenic patients , 1993, Biological Psychiatry.
[10] S. Kapur,et al. Relationship between dopamine D(2) occupancy, clinical response, and side effects: a double-blind PET study of first-episode schizophrenia. , 2000, The American journal of psychiatry.
[11] M. Wadenberg. Serotonergic mechanisms in neuroleptic-induced catalepsy in the rat , 1996, Neuroscience & Biobehavioral Reviews.
[12] S O Ogren,et al. Specific in vitro and in vivo binding of 3H-raclopride. A potent substituted benzamide drug with high affinity for dopamine D-2 receptors in the rat brain. , 1985, Biochemical pharmacology.
[13] P. Seeman,et al. Antipsychotic drugs which elicit little or no Parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors , 1998, Molecular Psychiatry.
[14] P. Voorn,et al. Effects of risperidone and haloperidol on tachykinin and opioid precursor peptide mRNA levels in the caudate‐putamen and nucleus accumbens of the rat , 1998, Synapse.
[15] G. Sedvall,et al. Positron emission tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Relation to extrapyramidal side effects. , 1992, Archives of general psychiatry.
[16] P. Elliott,et al. Neuroleptic-induced catalepsy as a model of Parkinson's disease I. Effect of dopaminergic agents , 1990, Journal of neural transmission. Parkinson's disease and dementia section.
[17] G. Sedvall,et al. Central D2-dopamine receptor occupancy in schizophrenic patients treated with antipsychotic drugs. , 1988, Archives of general psychiatry.
[18] Alan A. Wilson,et al. The D2 dopamine receptor occupancy of risperidone and its relationship to extrapyramidal symptoms: a PET study. , 1995, Life sciences.
[19] A Carlsson,et al. The current status of the dopamine hypothesis of schizophrenia. , 1988, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.
[20] O. Hornykiewicz,et al. Morphine catalepsy in the rat: relation to striatal dopamine metabolism. , 1972, European journal of pharmacology.
[21] M A Geyer,et al. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. , 1998, Schizophrenia bulletin.
[22] R. Baldessarini. Drugs and the treatment of psychiatric disorders , 1996 .
[23] G. Sedvall,et al. Quantitative analysis of D2 dopamine receptor binding in the living human brain by PET. , 1986, Science.
[24] Ching Chun Li,et al. Introduction to Experimental Statistics , 1965 .
[25] P. Sanberg. Haloperidol-induced catalepsy is mediated by postsynaptic dopamine receptors , 1980, Nature.
[26] S. Kapur,et al. Clinical and theoretical implications of 5-HT2 and D2 receptor occupancy of clozapine, risperidone, and olanzapine in schizophrenia. , 1999, The American journal of psychiatry.
[27] S. Kapur,et al. High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study. , 1996, The American journal of psychiatry.
[28] P. Seeman,et al. Atypical Neuroleptics Have Low Affinity for Dopamine D2 Receptors or Are Selective for D4 Receptors , 1997, Neuropsychopharmacology.
[29] P. Hicks,et al. The conditioned avoidance response test re-evaluated: is it a sensitive test for the detection of potentially atypical antipsychotics? , 1999, Neuroscience & Biobehavioral Reviews.
[30] S. Siegel,et al. Nonparametric Statistics for the Behavioral Sciences , 2022, The SAGE Encyclopedia of Research Design.
[31] R. Myers,et al. Quantitation of Carbon‐11‐labeled raclopride in rat striatum using positron emission tomography , 1992, Synapse.
[32] P. Seeman. Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. , 1992, Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology.